Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy
Authors:
- 1 March 2000
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 52 (3) , 267-271
Abstract
OBJECTIVE: Graves' ophthalmopathy (GO) and Graves' hyperthyroidism are closely associated diseases and thought to be caused by the same autoimmune process. An obvious explanation for this would be the presence of autoantibodies reacting with an autoantigen present in the orbit and the thyroid gland. The TSH‐Receptor (TSH‐R) antibodies are a likely candidate, because they cause Graves' hyperthyroidism and the TSH‐R appears to be present also in orbital tissues. If TSH‐R antibodies are responsible for the ophthalmopathy one would expect their titres to correlate with clinical characteristics of the eye disease. The aim of the present study is to see whether TSH‐R antibodies are related to the activity and severity of the thyroid‐associated ophthalmopathy.DESIGN AND PATIENTS: TSH‐R antibody levels were measured as TBII (TRAK assay), and TSI (cAMP response of a TSH‐R transfected cell line) in serum of 63 patients with untreated moderately severe GO, accompanying Graves' thyroid disease; all patients had been euthyroid for > 2 months.RESULTS: TBII and TSI titres were strongly related to each other. TBII or TSI titres did not correlate with thyroidal or orbital disease duration, nor with TPO antibody levels. In contrast, we found a striking and highly significant correlation between the Clinical Activity Score (CAS) of the eye disease, and both TBII (r = 0.54; P < 0.0001) and TSI (r = 0.50; P < 0.0001). In addition, a weaker but significant relation was found between proptosis (in mm) and TBII (r = 0.36; P = 0.004) and TSI (r = 0.49; P = 0.0001). No correlation was found with eye muscle motility.CONCLUSION: TSH‐R antibody levels correlate directly with clinical features of Graves' ophthalmopathy. The results support the hypothesis of a pathogenetic role of TSH‐R antibodies and the TSH‐R in the orbit of Graves' ophthalmopathy patients.Keywords
This publication has 20 references indexed in Scilit:
- The use of colour slides in the assessment of changes in soft-tissue involvement in Graves’ ophthalmopathyJournal of Endocrinological Investigation, 1998
- Thyrotropin Receptor Expression in Graves' Orbital Adipose/Connective Tissues: Potential Autoantigen in Graves' OphthalmopathyThe Journal of Clinical Endocrinology & Metabolism, 1998
- Involvement of the Orbital Fibroblast and TSH Receptor in the Pathogenesis of Graves' OphthalmopathyThyroid®, 1995
- Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissueThe Lancet, 1993
- Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule‐1 (ICAM‐1) in cultured Graves' orbital fibroblastsEuropean Journal of Clinical Investigation, 1992
- Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathyClinical Endocrinology, 1991
- Endocrine Ophthalmopathy: Current Ideas Concerning Etiology, Pathogenesis, and TreatmentEndocrine Reviews, 1984
- Progress in endocrine exophthalmos.BMJ, 1979
- Changes in Thyroid-Stimulating Immunoglobulins during Antithyroid Therapy*The Journal of Clinical Endocrinology & Metabolism, 1979
- Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' diseaseThe American Journal of Medicine, 1967